ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multiple Sclerosis Drugs Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38N2692
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Multiple Sclerosis Drugs Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-38N2692
Report
December 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation

Multiple Sclerosis Drugs Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Multiple Sclerosis Drugs Treatment Market

Multiple Sclerosis Drugs Treatment Market

Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of the course of disease as the characteristics, multiple sclerosis drug treatment can reduce the recurrence rate of this disease and slow down the process of disability.
Market Analysis and Insights: Global Multiple Sclerosis Drugs Treatment Market
The global Multiple Sclerosis Drugs Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Multiple Sclerosis Drugs Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Multiple Sclerosis Drugs Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiple Sclerosis Drugs Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multiple Sclerosis Drugs Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Multiple Sclerosis Drugs Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Multiple Sclerosis Drugs Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Multiple Sclerosis Drugs Treatment Market Report

Report Metric Details
Report Name Multiple Sclerosis Drugs Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Roche, Biogen, Teva Pharmaceutical, Merck, Novartis, Bayer, Sanofi, Acorda Therapeutics, Questcor Pharmaceuticals, AbbVie, Opexa Therapeutics, Genzyme Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Multiple Sclerosis Drugs Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Multiple Sclerosis Drugs Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiple Sclerosis Drugs Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Multiple Sclerosis Drugs Treatment Market report?

Ans: The main players in the Multiple Sclerosis Drugs Treatment Market are Pfizer, Roche, Biogen, Teva Pharmaceutical, Merck, Novartis, Bayer, Sanofi, Acorda Therapeutics, Questcor Pharmaceuticals, AbbVie, Opexa Therapeutics, Genzyme Corporation

What are the Application segmentation covered in the Multiple Sclerosis Drugs Treatment Market report?

Ans: The Applications covered in the Multiple Sclerosis Drugs Treatment Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other

What are the Type segmentation covered in the Multiple Sclerosis Drugs Treatment Market report?

Ans: The Types covered in the Multiple Sclerosis Drugs Treatment Market report are Interferon, Immunomodulator, Immunosuppressant

Recommended Reports

CNS & Neurology

Neurodegenerative Disorders

Autoimmune & Metabolic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Interferon
1.2.3 Immunomodulator
1.2.4 Immunosuppressant
1.3 Market by Application
1.3.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Sclerosis Drugs Treatment Market Perspective (2019-2030)
2.2 Global Multiple Sclerosis Drugs Treatment Growth Trends by Region
2.2.1 Multiple Sclerosis Drugs Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multiple Sclerosis Drugs Treatment Historic Market Size by Region (2019-2024)
2.2.3 Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2025-2030)
2.3 Multiple Sclerosis Drugs Treatment Market Dynamics
2.3.1 Multiple Sclerosis Drugs Treatment Industry Trends
2.3.2 Multiple Sclerosis Drugs Treatment Market Drivers
2.3.3 Multiple Sclerosis Drugs Treatment Market Challenges
2.3.4 Multiple Sclerosis Drugs Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Multiple Sclerosis Drugs Treatment by Players
3.1.1 Global Multiple Sclerosis Drugs Treatment Revenue by Players (2019-2024)
3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Multiple Sclerosis Drugs Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multiple Sclerosis Drugs Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Drugs Treatment Revenue in 2023
3.5 Global Key Players of Multiple Sclerosis Drugs Treatment Head office and Area Served
3.6 Global Key Players of Multiple Sclerosis Drugs Treatment, Product and Application
3.7 Global Key Players of Multiple Sclerosis Drugs Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Sclerosis Drugs Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2019-2024)
4.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2025-2030)
5 Multiple Sclerosis Drugs Treatment Breakdown Data by Application
5.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2019-2024)
5.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multiple Sclerosis Drugs Treatment Market Size (2019-2030)
6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type
6.2.1 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024)
6.2.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030)
6.2.3 North America Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
6.3 North America Multiple Sclerosis Drugs Treatment Market Size by Application
6.3.1 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024)
6.3.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030)
6.3.3 North America Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
6.4 North America Multiple Sclerosis Drugs Treatment Market Size by Country
6.4.1 North America Multiple Sclerosis Drugs Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024)
6.4.3 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Multiple Sclerosis Drugs Treatment Market Size (2019-2030)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type
7.2.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024)
7.2.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030)
7.2.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application
7.3.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024)
7.3.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030)
7.3.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
7.4 Europe Multiple Sclerosis Drugs Treatment Market Size by Country
7.4.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024)
7.4.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Multiple Sclerosis Drugs Treatment Market Size (2019-2030)
8.2 China Multiple Sclerosis Drugs Treatment Market Size by Type
8.2.1 China Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024)
8.2.2 China Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030)
8.2.3 China Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
8.3 China Multiple Sclerosis Drugs Treatment Market Size by Application
8.3.1 China Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024)
8.3.2 China Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030)
8.3.3 China Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Multiple Sclerosis Drugs Treatment Market Size (2019-2030)
9.2 Asia Multiple Sclerosis Drugs Treatment Market Size by Type
9.2.1 Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024)
9.2.2 Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030)
9.2.3 Asia Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
9.3 Asia Multiple Sclerosis Drugs Treatment Market Size by Application
9.3.1 Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024)
9.3.2 Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030)
9.3.3 Asia Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
9.4 Asia Multiple Sclerosis Drugs Treatment Market Size by Region
9.4.1 Asia Multiple Sclerosis Drugs Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Multiple Sclerosis Drugs Treatment Market Size by Region (2019-2024)
9.4.3 Asia Multiple Sclerosis Drugs Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Multiple Sclerosis Drugs Treatment Introduction
11.1.4 Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Multiple Sclerosis Drugs Treatment Introduction
11.2.4 Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.2.5 Roche Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Multiple Sclerosis Drugs Treatment Introduction
11.3.4 Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.3.5 Biogen Recent Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.4.5 Teva Pharmaceutical Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Multiple Sclerosis Drugs Treatment Introduction
11.5.4 Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Multiple Sclerosis Drugs Treatment Introduction
11.6.4 Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.6.5 Novartis Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Multiple Sclerosis Drugs Treatment Introduction
11.7.4 Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.7.5 Bayer Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Multiple Sclerosis Drugs Treatment Introduction
11.8.4 Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.8.5 Sanofi Recent Developments
11.9 Acorda Therapeutics
11.9.1 Acorda Therapeutics Company Details
11.9.2 Acorda Therapeutics Business Overview
11.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.9.4 Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.9.5 Acorda Therapeutics Recent Developments
11.10 Questcor Pharmaceuticals
11.10.1 Questcor Pharmaceuticals Company Details
11.10.2 Questcor Pharmaceuticals Business Overview
11.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Introduction
11.10.4 Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.10.5 Questcor Pharmaceuticals Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Multiple Sclerosis Drugs Treatment Introduction
11.11.4 AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.11.5 AbbVie Recent Developments
11.12 Opexa Therapeutics
11.12.1 Opexa Therapeutics Company Details
11.12.2 Opexa Therapeutics Business Overview
11.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.12.4 Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.12.5 Opexa Therapeutics Recent Developments
11.13 Genzyme Corporation
11.13.1 Genzyme Corporation Company Details
11.13.2 Genzyme Corporation Business Overview
11.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Introduction
11.13.4 Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024)
11.13.5 Genzyme Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation
List of Tables
    Table 1. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Interferon
    Table 3. Key Players of Immunomodulator
    Table 4. Key Players of Immunosuppressant
    Table 5. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Multiple Sclerosis Drugs Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2019-2024)
    Table 9. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2025-2030)
    Table 11. Multiple Sclerosis Drugs Treatment Market Trends
    Table 12. Multiple Sclerosis Drugs Treatment Market Drivers
    Table 13. Multiple Sclerosis Drugs Treatment Market Challenges
    Table 14. Multiple Sclerosis Drugs Treatment Market Restraints
    Table 15. Global Multiple Sclerosis Drugs Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Multiple Sclerosis Drugs Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Multiple Sclerosis Drugs Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2023)
    Table 18. Global Multiple Sclerosis Drugs Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Multiple Sclerosis Drugs Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Multiple Sclerosis Drugs Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Multiple Sclerosis Drugs Treatment, Product and Application
    Table 22. Global Key Players of Multiple Sclerosis Drugs Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Multiple Sclerosis Drugs Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Multiple Sclerosis Drugs Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Multiple Sclerosis Drugs Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Multiple Sclerosis Drugs Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Multiple Sclerosis Drugs Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Multiple Sclerosis Drugs Treatment Product
    Table 67. Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 68. Pfizer Recent Developments
    Table 69. Roche Company Details
    Table 70. Roche Business Overview
    Table 71. Roche Multiple Sclerosis Drugs Treatment Product
    Table 72. Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 73. Roche Recent Developments
    Table 74. Biogen Company Details
    Table 75. Biogen Business Overview
    Table 76. Biogen Multiple Sclerosis Drugs Treatment Product
    Table 77. Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 78. Biogen Recent Developments
    Table 79. Teva Pharmaceutical Company Details
    Table 80. Teva Pharmaceutical Business Overview
    Table 81. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product
    Table 82. Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 83. Teva Pharmaceutical Recent Developments
    Table 84. Merck Company Details
    Table 85. Merck Business Overview
    Table 86. Merck Multiple Sclerosis Drugs Treatment Product
    Table 87. Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 88. Merck Recent Developments
    Table 89. Novartis Company Details
    Table 90. Novartis Business Overview
    Table 91. Novartis Multiple Sclerosis Drugs Treatment Product
    Table 92. Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 93. Novartis Recent Developments
    Table 94. Bayer Company Details
    Table 95. Bayer Business Overview
    Table 96. Bayer Multiple Sclerosis Drugs Treatment Product
    Table 97. Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 98. Bayer Recent Developments
    Table 99. Sanofi Company Details
    Table 100. Sanofi Business Overview
    Table 101. Sanofi Multiple Sclerosis Drugs Treatment Product
    Table 102. Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 103. Sanofi Recent Developments
    Table 104. Acorda Therapeutics Company Details
    Table 105. Acorda Therapeutics Business Overview
    Table 106. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product
    Table 107. Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 108. Acorda Therapeutics Recent Developments
    Table 109. Questcor Pharmaceuticals Company Details
    Table 110. Questcor Pharmaceuticals Business Overview
    Table 111. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product
    Table 112. Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 113. Questcor Pharmaceuticals Recent Developments
    Table 114. AbbVie Company Details
    Table 115. AbbVie Business Overview
    Table 116. AbbVie Multiple Sclerosis Drugs Treatment Product
    Table 117. AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 118. AbbVie Recent Developments
    Table 119. Opexa Therapeutics Company Details
    Table 120. Opexa Therapeutics Business Overview
    Table 121. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product
    Table 122. Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 123. Opexa Therapeutics Recent Developments
    Table 124. Genzyme Corporation Company Details
    Table 125. Genzyme Corporation Business Overview
    Table 126. Genzyme Corporation Multiple Sclerosis Drugs Treatment Product
    Table 127. Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2019-2024) & (US$ Million)
    Table 128. Genzyme Corporation Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Multiple Sclerosis Drugs Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Interferon Features
    Figure 4. Immunomodulator Features
    Figure 5. Immunosuppressant Features
    Figure 6. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Pharmacy Case Studies
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. Online Pharmacy Case Studies
    Figure 11. Other Case Studies
    Figure 12. Multiple Sclerosis Drugs Treatment Report Years Considered
    Figure 13. Global Multiple Sclerosis Drugs Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Multiple Sclerosis Drugs Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Multiple Sclerosis Drugs Treatment Market Share by Region: 2023 VS 2030
    Figure 16. Global Multiple Sclerosis Drugs Treatment Market Share by Players in 2023
    Figure 17. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Multiple Sclerosis Drugs Treatment Revenue in 2023
    Figure 19. North America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
    Figure 21. North America Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
    Figure 22. North America Multiple Sclerosis Drugs Treatment Market Share by Country (2019-2030)
    Figure 23. United States Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Multiple Sclerosis Drugs Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
    Figure 27. Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
    Figure 28. Europe Multiple Sclerosis Drugs Treatment Market Share by Country (2019-2030)
    Figure 29. Germany Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Multiple Sclerosis Drugs Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
    Figure 37. China Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
    Figure 38. Asia Multiple Sclerosis Drugs Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
    Figure 40. Asia Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
    Figure 41. Asia Multiple Sclerosis Drugs Treatment Market Share by Region (2019-2030)
    Figure 42. Japan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Multiple Sclerosis Drugs Treatment Market Share by Country (2019-2030)
    Figure 52. Brazil Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 59. Roche Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 60. Biogen Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 61. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 62. Merck Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 64. Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 65. Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 66. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 67. Questcor Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 68. AbbVie Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 69. Opexa Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 70. Genzyme Corporation Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Multiple Sclerosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multiple Sclerosis MS Drugs Market Research Report 2025
Global Scleroderma Therapeutics Market Insights Forecast to 2030
Global Targeted Drugs for Multiple Sclerosis Market Research Report 2024
Relapsing Multiple Sclerosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Multiple Sclerosis Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Demyelinating Diseases Therapeutics Market Research Report 2024
Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Central Nervous System Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Systemic Sclerosis Treatments Market Research Report 2024
Global Optic Nerve Disorders Treatment Market Insights Forecast to 2030
Encephalomyelitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Scleroderma Drug Market Insights Forecast to 2030
Global Neurologic Disorder Treatment Drug Market Research Report 2024
Global Systemic Sclerosis Drug Market Research Report 2025
Global Scleroderma Treatment Market Research Report 2025
Global Devic s Syndrome Neuromyelitis Optica Treatment Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions